Scale expansion through M&A in the dispensing pharmacy business
First written in FY2016. 23 of 24 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-11-10.
2 other companies' latest entry also says "Advanced".
- 2026-11-10AdvancedResults
「Ｍ＆Ａにより地域薬局１店舗を取得しました。」
当中間期に地域薬局1店舗をM&Aで取得した。 - FY2026AdvancedAnnual report
「During the consolidated fiscal year, we opened 17 new regional pharmacies, including 13 mall-format stores, and acquired 9 regional pharmacies through M&A.」
In regional pharmacy M&A, we acquired 9 stores during the fiscal year and expanded the business together with new store openings. - FY2026-H1AdvancedAnnual report
「The regional pharmacy segment continued to focus on opening new stores, opening 7 new regional pharmacies, including 5 mall-format stores, during the six-month consolidated accounting period, and acquiring 8 regional pharmacies through M&A.」
In dispensing pharmacy M&A, we acquired 8 regional pharmacies during the six-month consolidated accounting period. - FY2025AdvancedAnnual report
「During the consolidated fiscal year, we opened 21 new regional pharmacies, including 12 mall-format stores, and acquired 1 regional pharmacy through M&A, while closing 15 stores and transferring businesses.」
In addition to opening new stores, we acquired 1 regional pharmacy through M&A. We also closed stores and transferred businesses. - FY2025-H1AdvancedAnnual report
「During the six-month consolidated accounting period, we opened 11 new regional pharmacies, including 7 mall-format stores, and acquired 1 regional pharmacy through M&A, while closing 10 stores and transferring businesses.」
In the regional pharmacy business, we opened 11 new stores and acquired 1 store through M&A, while also closing 10 stores and transferring businesses. - FY2023-Q3AdvancedAnnual report
「In addition, during the nine-month period ended [third quarter], we opened 6 new regional pharmacies, including 5 mall-format stores, and acquired 1 company with 1 store through a share acquisition.」
We acquired 1 company with 1 store through a share acquisition and continued expanding the regional pharmacy network through M&A. In addition, consolidated subsidiary 株式会社なの花東日本 acquired all shares of 有限会社イワミ堂薬局 effective 22 November 2022. - FY2023-Q2AdvancedAnnual report
「In the regional pharmacy segment, prescription revenue per prescription declined due to the impact of revisions to drug prices and dispensing fees, but the number of prescriptions filled increased, partly because of contributions from newly opened stores and stores acquired through M&A.」
New store openings and stores acquired through M&A contributed to results, increasing the number of prescriptions filled. - FY2022AdvancedAnnual report
「The consolidated subsidiary ㈱なの花北海道 acquired all shares of ㈲クリニクス on 1 April 2021.」
なの花北海道 acquired all shares of クリニクス, continuing M&A in the dispensing pharmacy business. - FY2022-Q1AdvancedAnnual report
「The consolidated subsidiary なの花北海道 acquired all shares of 有限会社クリニクス on 1 April 2021.」
The disclosure recorded the specific execution of M&A in the dispensing pharmacy business through the acquisition of all shares of 有限会社クリニクス. - FY2021AdvancedAnnual report
「The consolidated subsidiary なの花東日本 acquired all shares of メトロファーマシー on 8 February 2021.」
The disclosure recorded the specific execution of M&A in the dispensing pharmacy business through the acquisition of all shares of メトロファーマシー. - FY2020-Q3AdvancedAnnual report
「During the consolidated third quarter, ㈱なの花東日本, a consolidated subsidiary, acquired all shares of ㈱セントラルファーマシー, which was consequently included in the scope of consolidation.」
Executed M&A in the dispensing pharmacy business through the acquisition of all shares of セントラルファーマシー on 27 November 2019. - FY2020-Q1AdvancedAnnual report
「In the dispensing pharmacy segment, performance was supported by stores acquired through M&A, in addition to steady sales at existing stores. As of 30 June 2019, the store count was 421 dispensing pharmacies, 1 care plan center and 8 drugstores.」
The contribution to performance from stores acquired through M&A was evident, and the number of dispensing pharmacy stores reached 421. - FY2019AdvancedAnnual report
「永冨調剤薬局, which became a consolidated subsidiary through a share acquisition in January 2019, operated 23 stores in Oita Prefecture, significantly strengthening the Company's dominant presence in the Kyushu region.」
Acquired 永冨調剤薬局 in January 2019, strengthening the Company's dominant presence in Kyushu by adding its 23 stores in Oita Prefecture. - FY2019-Q3AdvancedAnnual report
「During the cumulative consolidated period of the third quarter, the Company opened 5 new dispensing pharmacies and acquired 1 company with 2 stores through a share acquisition and 5 stores through business acquisitions, while closing 5 dispensing pharmacies and 1 drugstore.」
Acquired 1 company with 2 stores through a share acquisition and 5 stores through business acquisitions, advancing M&A and business acquisitions in the dispensing pharmacy business. Meanwhile, it closed 5 dispensing pharmacies and 1 drugstore. - FY2019-Q2AdvancedAnnual report
「During the cumulative consolidated period of the second quarter, the Company opened 2 new dispensing pharmacies and acquired 5 stores through a business acquisition, while closing 1 dispensing pharmacy and 1 drugstore.」
Acquired 5 dispensing pharmacies through a business acquisition and, together with 2 new store openings, expanded the pharmacy network, while closing 1 dispensing pharmacy and 1 drugstore. - FY2019-Q1AdvancedAnnual report
「During the cumulative consolidated period of the first quarter, the Company opened 2 new dispensing pharmacies and acquired 5 stores through a business acquisition, while closing 1 drugstore.」
Acquired 5 dispensing pharmacies through a business acquisition and, together with 2 new store openings, expanded the pharmacy network. - FY2018AdvancedAnnual report
「The Company opened 8 new dispensing pharmacies and acquired 7 companies (19 stores) through share acquisitions, while closing 3 stores and transferring 2 businesses.」
Acquired 7 companies with 19 stores through share acquisitions and, together with 8 new store openings, expanded the pharmacy network. In January 2018, the Company acquired Apotek and its 4 wholly owned subsidiaries, adding a base in the Tohoku region with 14 stores across the group. - FY2018-Q3AdvancedAnnual report
「During the cumulative consolidated period of the third quarter, the Company opened 8 new dispensing pharmacies and acquired 3 companies (5 stores) through share acquisitions, while closing 3 stores and transferring 2 businesses.」
Acquired 3 companies with 5 stores through share acquisitions and, together with 8 new store openings, expanded the dispensing pharmacy network, while also carrying out closures and business transfers. - FY2018-Q2AdvancedAnnual report
「During the cumulative consolidated period of the second quarter, the Company opened 6 new dispensing pharmacies and acquired 3 companies (5 stores) through share acquisitions, while closing 3 stores and transferring 1 business.」
Acquired 3 companies with 5 stores through share acquisitions and, together with 6 new store openings, expanded the dispensing pharmacy network, while also carrying out closures and business transfers. - FY2017AdvancedAnnual report
「The Company opened 8 new dispensing pharmacies, acquired 8 companies (18 stores) through share acquisitions and 2 stores through business acquisitions, while closing 4 stores and transferring businesses.」
Advanced M&A and business acquisitions in the dispensing pharmacy business by acquiring 8 companies with 18 stores through share acquisitions and 2 stores through business acquisitions. - FY2017-Q3AdvancedAnnual report
「During the cumulative consolidated period of the third quarter, the Company opened 8 new dispensing pharmacies and acquired 7 companies (17 stores) through share acquisitions and 2 stores through business acquisitions, while closing 3 stores and transferring businesses.」
Acquired 7 companies with 17 stores through share acquisitions and 2 stores through business acquisitions, advancing M&A and business acquisitions in the dispensing pharmacy business. - FY2017-Q2AdvancedAnnual report
「During the cumulative consolidated period of the second quarter, the Company opened 7 new dispensing pharmacies, acquired 5 companies (15 stores) through share acquisitions and 2 stores through business acquisitions, while closing 3 stores and transferring businesses.」
Advanced M&A and business acquisitions in the dispensing pharmacy business by acquiring 5 companies with 15 stores through share acquisitions and 2 stores through business acquisitions. - FY2017-Q1AdvancedAnnual report
「During the first quarter of the fiscal year under review, the Company opened 6 dispensing pharmacies, acquired 13 pharmacies through the acquisition of 3 companies and acquired 2 pharmacies through business transfers, while closing 1 store.」
Executed M&A and business acquisitions in the dispensing pharmacy business by acquiring 3 companies with 13 stores through share acquisitions and 2 stores through business acquisitions. - FY2016First statedAnnual report
「Promoting M&A in the dispensing pharmacy business」
The policy is to prioritize profitability and make focused investments in areas where medical demand is expected.